Home › Funds › Pale Fire Capital SE › RGNX

Pale Fire Capital SE position in RGNX

REGENXBIO INC · Health Care

Pale Fire Capital SE reported holding 23,184 shares of RGNX (REGENXBIO INC) in its Q3 2026 13F filing — a position valued at US$175K, representing 0.01% of its reported portfolio and ranking #50 among its reported holdings. Pale Fire Capital SE has disclosed RGNX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)23.18K sh
Reported value held$174.58K
Portfolio Weight0.01%
First reportedQ4 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Pale Fire Capital SE's RGNX position evolved

Pale Fire Capital SE first disclosed a stake in RGNX in Q4 2024 at 11,721 shares (US$91K). The position peaked in Q4 2025 at 499,526 shares, worth US$7.2M. Across 8 filings, Pale Fire Capital SE increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 23,184 shares valued at US$175K — a reduction of -443,025 shares quarter over quarter.. Notable position changes include a 121% increase in Q1 2025 (shares rose 15% over the following quarter), a 818% increase in Q3 2025 (shares rose 49% over the following quarter), a 95% increase in Q4 2025 (shares fell 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 11.72K $90.60K New
Q1 2025 25.85K $184.80K Add
Q2 2025 27.85K $228.62K Add
Q3 2025 255.60K $2.47M Add
Q4 2025 499.53K $7.19M Add
Q1 2026 493.73K $4.14M Reduce
Q2 2026 466.21K $5.59M Reduce
Q3 2026 23.18K $174.58K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGNX and 13F data

RGNX (REGENXBIO INC) is a Health Care company. 27 other funds we track also report a position in RGNX — the largest reported positions include Redmile Group, LLC (US$52.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGNX

All RGNX fund holders →

FAQ

How long has Pale Fire Capital SE held RGNX?

Pale Fire Capital SE has disclosed RGNX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Pale Fire Capital SE's current position in RGNX?

As of Q3 2026, Pale Fire Capital SE holds 23.18K shares of RGNX (REGENXBIO INC), valued at $174.58K, representing 0.01% of its reported portfolio and ranking #50.

Has Pale Fire Capital SE been buying or selling RGNX?

In the latest 13F filing (Q3 2026), Pale Fire Capital SE reduced its position in RGNX. The position peaked in Q4 2025 at 499.53K shares.

Which other funds hold RGNX?

Other major institutional holders of RGNX include Redmile Group, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.